420 related articles for article (PubMed ID: 27841659)
1. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
[TBL] [Abstract][Full Text] [Related]
2. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.
Jin K; Luo G; Xiao Z; Liu Z; Liu C; Ji S; Xu J; Liu L; Long J; Ni Q; Yu X
Drug Des Devel Ther; 2015; 9():1247-55. PubMed ID: 25750521
[TBL] [Abstract][Full Text] [Related]
4. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
Reese M; Dhayat SA
J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
6. Research progress on circularRNAs in pancreatic cancer: emerging but promising.
Wang YZ; An Y; Li BQ; Lu J; Guo JC
Cancer Biol Ther; 2019; 20(9):1163-1171. PubMed ID: 31138014
[TBL] [Abstract][Full Text] [Related]
7. Role of non-coding RNAs in pancreatic cancer: the bane of the microworld.
Tang YT; Xu XH; Yang XD; Hao J; Cao H; Zhu W; Zhang SY; Cao JP
World J Gastroenterol; 2014 Jul; 20(28):9405-17. PubMed ID: 25071335
[TBL] [Abstract][Full Text] [Related]
8. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
9. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
10. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Jia Y; Shen M; Zhou Y; Liu H
Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
[TBL] [Abstract][Full Text] [Related]
11. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
12. Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.
Garajová I; Balsano R; Tommasi C; Giovannetti E
Curr Pharm Des; 2018; 24(39):4601-4604. PubMed ID: 30659532
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
[TBL] [Abstract][Full Text] [Related]
14. Contributions of Gene Modules Regulated by Essential Noncoding RNA in Colon Adenocarcinoma Progression.
Li C; Yu X; Lu J; Zheng L; Xu D; Xu Z; Wang L; Cui Y; Li Y; Wang H; Xu J; Li K
Biomed Res Int; 2020; 2020():8595473. PubMed ID: 32280704
[TBL] [Abstract][Full Text] [Related]
15. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
16. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
17. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
18. The regulatory roles of long noncoding RNAs in the biological behavior of pancreatic cancer.
Li Y; Yang X; Kang X; Liu S
Saudi J Gastroenterol; 2019; 25(3):145-151. PubMed ID: 30720003
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNAs in pancreas cancer: from biomarkers to therapeutic targets.
Güzel Tanoğlu E; Adigüzel S; Tanoğlu A; Aydin ZB; Hocaoğlu G; Ebinç S
Turk J Med Sci; 2023; 53(6):1552-1564. PubMed ID: 38813489
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers.
Moro L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
